Reducing the problems of the progestogen

The Million Women Study also reported a significantly increased risk of breast cancer with CEPT and a lower, though still an increased, risk with unopposed estrogen, prompting the authors to suggest that the addition of progestogen, even for women who have not had a hysterectomy, is not worth the ex...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Climacteric : the journal of the International Menopause Society 2006-08, Vol.9 (4), p.241-243
Hauptverfasser:	Sturdee, David W., MacLennan, Alastair H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Breast Neoplasms - chemically induced Cardiovascular system Endometrial cancer Endometrial Neoplasms - chemically induced Endometrial Neoplasms - prevention & control Estrogen Replacement Therapy - adverse effects Estrogen Replacement Therapy - methods Female Hormone replacement therapy Humans Hysterectomy Progesterone Progestins - administration & dosage Progestins - adverse effects Risk Factors Side effects Women's Health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The Million Women Study also reported a significantly increased risk of breast cancer with CEPT and a lower, though still an increased, risk with unopposed estrogen, prompting the authors to suggest that the addition of progestogen, even for women who have not had a hysterectomy, is not worth the extra risk of breast cancer, and that unopposed estrogen should be considered for all women2.
ISSN:	1369-7137 1473-0804
DOI:	10.1080/13697130600877522